Johnson and Johnson - Short Term - We look to Sell at 176.93 (stop at 178.95) Previous resistance located at 176.00. We look to sell rallies. This provides an excellent risk/reward opportunity to fade the current bullish move. Although the anticipated move lower is corrective, it does offer ample risk/reward today. Our profit targets will be 172.09 and 168.20...
Immediate targets at 165, 156, 149. Invalidation at 194. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically...
Initial entry 162 Re Entered at 164, stop 155, target 170.
Johnson & Johnson is a leader in several areas of pharmaceutical research, including oncology and immunologic diseases. The company's portfolio of drugs in these two areas brings in billions of dollars in revenue each quarter. The company is currently seeking to strengthen its market share in COVID-19 vaccines. This year, Johnson & Johnson anticipates generating...
SNIPER STRATEGY This magical strategy works like a clock on almost any charts Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading. It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave. The best timeframe for this strategy is Daily, Weekly and Monthly...
Large cap stonks & crypto Ponzi Pogs collapse. *valuation matters
Johnson & Johnson is a major manufacturer of cosmetic and sanitary products, as well as medical equipment and medicines. The company was founded in 1886. In general, the history of the company is mega-successful. The corporation expanded through the purchases of competitors and gained more and more market share in its areas. The company's progress is confirmed...
the trend is intact. No technical, let alone fundamental, reason to lose it. So there is no reason not to stay long in the long term, from today's perspective. may the price action is with U! aaron
Price was out of the water of the Bollinger Bands. Look for price to come back into the water to fill the gap and then we may see the downward pressure resume.
With the news that the CDC is pausing J&J vaccine distribution due to blood clot issues. I'm assuming we should see it tank at the open? You're guess is as good as mine. In my opinion if we see price drop it should be a good time to buy, because everyone else is selling. The level I'm interested in is $147-$150. It is an untested point of control where...
Look for Johnson and Johnson to hit the second target zone to the downside.
Johnson & Johnson (JNJ), D1: Support line + Mirror level + Bollinger bands + Inside bar
- CROSSED TRENDLINE 22 JAN 2018 - - MORE SPACE TO RUN - - BUY LONG - - CURRENT TREND: BULL -
J&J has activated a second impulse structure with target price at $180.35 that is +17% from current price. This value has as well a bigger second impulse structure activated with target price $228.66 +48% from current price.
There is a great deal to be bullish about for JNJ. I anticipate the price will find a nice runup as the recent bullish volume along with strong institutional exposure (70%) leads me to believe we find the price moving higher. The other fascinating observation is the strong earnings growth with virtually no new sales growth. This is a company run incredibly well...
I can't look at a whole bunch of pharma stocks and just skip JnJ. For the uninitiated, this is the largest Pharmaceutical company in the world (by far) and a major, major player in the world of medical devices and OTC consumables as well. Anyway, down we go, and, not financial advice.
JNJ Entry Price 143.96, Target Price 147.47